Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 516-520

  Javadi, Morteza ^a   Hematti, Simin ^a   Tavassoli, Manoochehr ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Breast cancer; IGF 1; Microsatellite; Polymorphism

Indexed keywords

SOMATOMEDIN C;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSINE ADENINE DINUCLEOTIDE REPEAT LENGTH POLYMORPHISM; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; IRAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RISK ASSESSMENT; BREAST TUMOR; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; PROGNOSIS;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; IRAN; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC;

EID: 84866269181     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9936-6     Document Type: Article

References (29)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229-39.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71-96.
3. Sondik EJ. Breast cancer trends. Incidence, mortality, and survival. Cancer. 1994;74:995-9.
4. Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O'Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer. 2002;94:1175-82.
5. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13:383-91.
6. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsedeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20:556-63.
7. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, Mehrabi Y. Reproductive characteristics and the risk of breast cancer-a case-control study in Iran. Asian Pac J Cancer Prev. 2005;6:370-5.
8. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: result of a multi-center study. Asian Pac J Cancer Prev. 2004;5:24.
9. Kleinberg DL, Ruan W, Catanese V, Newman CB, Feldman M. Non-lactogenic effects of growth hormone on growth and insulinlike growth factor-I messenger ribonucleic acid of rat mammary gland. Endocrinology. 1990;126:3274-6.
10. Walden PD, Ruan W, Feldman M, Kleinberg DL. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology. 1998;139:659-62.
11. Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the long island breast cancer study project. Carcinogenesis. 2006;27:758-65.
12. Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM, Lamberts SW. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol. 2003;148:171-5.
13. Tran N, Bharaj BS, Diamandis EP, Smith M, Li BD, Yu H. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiol Biomarkers Prev. 2004;13:2133-40.
14. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:2-19.
15. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SWJ, Oostra BA, Pols HAP, van Duijn CM. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes. 2001;50:637-42.
16. Yu H, Li BD, Smith M, Shi R, Berkel HJ, Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat. 2001;70:117-22.
17. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN, Hankinson SE. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer. 2002;100:332-6.
18. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes. 2002;51:2313-6.
19. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab. 1998;83:2286-90.
20. Fehringer G, Boyd NF, Knight JA, Paterson AD, Dite GS, Giles GG, Southey MC, Andrulis IL, Hopper JL, Ozcelik H. Familybased genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk. Breast Cancer Res Treat. 2009;118:415-24.
21. Allen NE, Roddam AW, Allen DS, Fentiman IS, Dos Santos Silva I, Peto J, Holly JM, Key TJ. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein- 3 and breast cancer risk. Br J Cancer. 2005;92:1283-7.
22. DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer. 2003;88:277-82.
23. Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer. 2005;113:307-11.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
25. Tsuchiya N, Wang L, Suzuki H, Segawa T, Fukuda H, Narita S, Shimbo M, Kamoto T, Mitsumori K, Ichikawa T, Ogawa O, Nakamura A, Habuchi T. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. J Clin Oncol. 2006;24:1982-9.
26. Bågeman E, Ingvar C, Rose C, Jernström H. Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women. Br J Cancer. 2007;96:712-7.
27. Jami MS, Hemati S, Salehi Z, Tavassoli M. Association between the length of CA dinucleotide repeat in the EGFR and risk of breast cancer. Cancer Invest. 2008;26:434-7.
28. González-Zuloeta Ladd AM, Vásquez AA, Rivadeneira F, Siemes C, Hofman A, Stricker BH, Pols HA, Uitterlinden AG, van Duijn CM. Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat. 2008;107:415-9.
29. Chen X, Guan J, Song Y, Chen P, Zheng H, Tang C, Wu Q. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis. J Hum Genet. 2008;53:227-38.